Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   Abstract views HTML views PDF downloads Totals
10,062 Dovepress* 4,883 2,397+ 1,455 7,280
PubMed Central* 0 2,782 934 2,782
Totals 4,883 5,179 2,389 10,062
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 4 6

View citations on PubMed Central and Google Scholar